Online citations, reference lists, and bibliographies.
← Back to Search

Anti‐mesothelial Markers In Sarcomatoid Mesothelioma And Other Spindle Cell Neoplasms

R. Attanoos, S. Dojcinov, R. Webb, A. Gibbs
Published 2000 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Aims
This paper references
Pleural mesothelioma of connective tissue type, localised fibrous tumour of the pleura, and reactive submesothelial hyperplasia
M Al-Izzi (1989)
`Pleural' and pulmonary carcinosarcoma
FG Mayall (1992)
Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of mesothelioma
RL Attanoos (1997)
10.1093/AJCP/92.5.566
Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
P. Cagle (1989)
10.1016/0046-8177(94)90243-7
Desmin and neural marker expression in mesothelial cells and mesotheliomas.
J. Hurlimann (1994)
10.1046/j.1365-2559.1997.d01-611.x
Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of diffuse malignant mesothelioma
R. Attanoos (1997)
Sarcomas of the lung.
A. Nascimento (1982)
10.1097/00000478-199609000-00001
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
The calcium binding protein calretinin is a selective marker for malignant pleural mesothelioma of the epithelial type
V Gotzos (1996)
10.1111/j.1365-2559.1996.tb01393.x
Mesothelioma‐binding antibodies: thrombomodulin, OV 632 and HBME‐1 and their use in the diagnosis of malignant mesothelioma
R. Attanoos (1996)
10.1007/978-1-4684-5754-4_32
Calretinin and other CaBPs in the nervous system.
J. Rogers (1990)
Pathology and diagnosis of mesothelioma
DW Henderson (1992)
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and 230
I Maruyama (1985)
Pathology of human mesothelioma
JL Roggli (1987)
10.1002/PATH.1711760413
Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti‐inflammatory therapy
I. Appleton (1995)
10.1016/0046-8177(93)90080-Z
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
R. Brown (1993)
Immunohistochemical diagnosis of mesothelioma
J. Legier (1994)
10.1016/S0046-8177(88)80529-X
Keratin protein immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesothelioma: an immunoperoxidase study of 30 cases.
A. Montag (1988)
10.1046/j.1365-2559.1998.00349.x
E‐cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma
Leers (1998)
Sarcomatoid (spindle cell) mesothelioma of pleura
N Azumi (1989)
10.1016/0007-0971(88)90042-3
Cryptogenic bilateral fibrosing pleuritis.
D. R. Buchanan (1988)
10.1111/j.1365-2559.1992.tb00430.x
Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon
F. Mayall (1992)
10.1016/0007-0971(78)90057-8
Pulmonary and pleural lesions in rheumatoid disease.
J. D. Macfarlane (1978)
10.1002/PATH.1711670308
‘Pleural’ and pulmonary carcinosarcomas
F. Mayall (1992)
10.1016/S0344-0338(96)80208-1
The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
V. Gotzos (1996)
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.
C. L. Collins (1992)
10.1002/PATH.1711700211
The diagnostic implications of variable cytokeratin expression in mesotheliomas
F. Mayall (1993)
10.1097/00000478-198810000-00002
Three Types of Spindle Cell Tumors of the Pleura: Fibroma, Sarcoma, and Sarcomatoid Mesothelioma
D. Carter (1988)
10.1111/j.1365-2559.1995.tb00214.x
Smooth muscle tumours presenting as pleural neoplasms
C. Moran (1995)
10.1046/j.1365-2559.1998.00565.x
Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases
Nicholson (1998)
Malignant fibrosarcomatoid mesothelioma and benign pleural fibroma (localized fibrous mesothelioma) in tissue culture
E Alvarez-Fernandez (1979)
10.1016/0166-2236(92)90081-I
Calcium-binding proteins in the nervous system
K. Baimbridge (1992)
10.1007/BF02890064
Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas
R. Moll (1989)
10.1046/j.1365-2559.1997.d01-590.x
CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma
R. Attanoos (1997)
10.1097/00000478-199612000-00001
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases.
B. T. Lin (1996)
Sarcomatoid ( spindle cell ) mesothelioma of pleura . Immunohistochemical studies
N Azumi (1989)
10.1046/j.1365-2559.1996.d01-481.x
Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 14 cases
R. Attanoos (1996)
Malignant mesotheliomas with osseous and cartilaginous differentiation.
S. Yousem (1987)
10.1136/thx.42.8.583
Asbestos induced diffuse pleural fibrosis: pathology and mineralogy.
M. Stephens (1987)
10.1111/j.1365-2559.1987.tb02656.x
Cytokeratin expression in smooth muscle and smooth muscle tumours
D. C. Brown (2002)
10.1097/00000478-198204000-00003
Desmoplastic diffuse mesothelioma
R. Cantin (1982)
10.1002/PATH.1711580109
Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison
M. Al-Izzi (1989)
Angiosarcoma of serous membranes.
W. Mccaughey (1983)
Pathology of human mesothelioma. Etiologic and diagnostic considerations.
V. Roggli (1987)
Malignant vascular tumours of the serous membranes mimicking mesothelioma
BT-Y Lin (1996)
Tumour and pseudotumours of the serosal membrane
H Battifora (1995)
Thrombomodulin as a marker of lymphatic endothelium
MAC Appleton (1995)
Localised malignant mesothelioma: a clinicopathologic and cytometric study
TB Crotty (1994)
Pulmonary and pleural disease in rheumatoid disease
JD McFarlane (1978)
10.1046/j.1365-2559.1997.6020829.x
Value of thrombomodulin immunostaining in the diagnosis of mesothelioma
N. Ordóñez (1997)
10.1097/00000478-199404000-00004
Localized Malignant Mesothelioma: A Clinicopathologic and Flow Cytometric Study
T. Crotty (1994)
10.1007/BF02932860
Keratin in the epithelial-like cells of classical biphasic synovial sarcoma
M. Miettinen (1982)
10.1016/0002-9343(77)90154-1
Carcinomatous involvement of the pleura: an analysis of 96 patients.
B. Chernow (1977)
10.1046/j.1365-2559.1997.2150833.x
Anti‐cytokeratin 5/6: a positive marker for epithelioid mesothelioma
J. Clover (1997)
10.1002/1097-0142(197905)43:5<1658::AID-CNCR2820430515>3.0.CO;2-Y
Malignant fibrosarcomatous mesothelioma and benign pleural fibroma (localized fibrous mesothelioma) in tissue culture: A comparison of the in Vitro pattern of growth in relation to the cell of origin
E. Alvarez-Fernández (1979)
10.1083/JCB.101.2.363
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta
I. Maruyama (1985)



This paper is referenced by
10.1016/S0761-8425(06)71781-8
1. Comment évaluer une exposition à l’amiante et identifier une population à risque?
J. Pairon (2006)
10.17221/7143-VETMED
Pericardial mesothelioma in a German Shepherd dog: a case report
Songul Ceribasi (2018)
10.1016/J.HUMPATH.2005.01.019
D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
N. Ordóñez (2005)
10.1700/1660.18182
Expression of Thrombomodulin, Calretinin, Cytokeratin 5/6, D2–40 and WT-1 in a Series of Primary Carcinomas of the Lung: An Immunohistochemical Study in Comparison with Epithelioid Pleural Mesothelioma
C. Comin (2014)
10.1007/978-1-84628-012-2
Pathology of Malignant Mesothelioma
F. Galateau-Sallé (2006)
10.1097/PAI.0b013e31828a83c5
Value of Podoplanin as an Immunohistochemical Marker in Tumor Diagnosis: A Review and Update
N. Ordóñez (2014)
10.1111/j.1365-2559.2003.01679.x
Melanoma arising in and limited to a spinal nerve root of the cauda equina
A. Sanz-Trelles (2003)
10.1046/j.1365-2559.2001.01295.x
Malignant epithelioid mesothelioma: anti‐mesothelial marker expression correlates with histological pattern
R. Attanoos (2001)
10.1002/DC.10141
Peritoneal washing cytology findings of disseminated myxoid leiomyosarcoma of uterus: Report of a case with emphasis on possible differential diagnosis
W. Ng (2002)
10.1046/j.1365-2559.2002.01422.x
Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma
R. Attanoos (2002)
10.1080/15321819.2012.690356
IS GALECTIN-3 ANTIBODY A USEFUL MARKER IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA?
Mona Mlika (2013)
10.1007/s11748-019-01182-8
Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: a report of autopsy case that accomplished trimodality therapy and review of the literature
H. Itano (2019)
10.1053/j.semtcvs.2009.06.005
Pathologic evaluation of malignant pleural mesothelioma.
L. Chirieac (2009)
10.1016/j.jtho.2018.04.023
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
F. Sallé (2018)
10.1016/B978-0-323-44284-8.00021-1
Malignant and Borderline Mesothelial Tumors of the Pleura
M. R. Wick (2011)
10.1501/VETFAK_0000002518
Mesothelioma in a dog
Kübra Asena Terim Kapakin (2012)
10.1043/1543-2165(2008)132[1104:PST]2.0.CO;2
Pulmonary sarcomatous tumors.
L. Litzky (2008)
10.5348/EJC01-2013-1-OA-1
A retrospective study of 53 cases of primary tumors of the pleura diagnosed over a 16-year period
M. Mlika (2013)
10.1111/j.1365-2559.2003.01703.x
Cytokeratin‐positive malignant solitary fibrous tumour of the pleura: an unusual pitfall in the diagnosis of pleural spindle cell neoplasms
A. Cavazza (2003)
10.1097/01.pap.0000213064.05005.64
Applications and Limitations of Immunohistochemistry in the Diagnosis of Malignant Mesothelioma
S. Suster (2006)
10.1016/B978-0-7020-3369-8.00013-6
Chapter 13 – Pleura and chest wall
B. Corrin (2011)
10.1007/978-1-4471-2825-0_16
Malignant Mesothelioma: Pathology
S. Anttila (2014)
Étude du profil mutationnel K-RAS, EGFR, LKB1 et de la transition épithélio-mésenchymateuse dans une série de 22 carcinomes sarcomatoïdes pulmonaires
M. Rabeyrin (2011)
10.1177/039463200902200106
CXCR4+FOXP3+CD25+ Lymphocytes Accumulate in CXCL12-Expressing Malignant Pleural Mesothelioma
Y. Shimtzu (2009)
10.1097/01.PCR.0000204709.30831.C8
Malignant Mesothelioma: Fluid Cytology and Differential Diagnostic Features
T. Bhatti (2006)
10.1007/978-3-319-99510-6_2
Pathology of Selected Primary and Metastatic Tumors of Peritoneum
Kozlov A. Nikolay (2019)
10.1097/PAS.0b013e31814faacf
Podoplanin is a Better Immunohistochemical Marker for Sarcomatoid Mesothelioma Than Calretinin
Diana M Padgett (2008)
10.1136/JCP.54.10.766
Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry.
F. Roberts (2001)
10.1016/S0210-4806(06)73460-X
Expresión de Citoqueratina 5 y Calretinina en el carcinoma renal de células claras
P. C. Mouteira (2006)
10.1053/J.SEMDP.2006.06.002
Spindle cell tumors of the pleura: differential diagnosis.
M. Rdzanek (2006)
10.1038/modpathol.3880483
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
P. Chu (2002)
10.5795/JJSCC.47.301
肉腫型胸膜悪性中皮腫の 1 例
勝明 佐藤 (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar